Bayer, J&J stroke drug not ready for approval: FDA
WASHINGTON (Reuters) – Drug regulators said an experimental stroke preventer from Bayer and Johnson & Johnson is not ready for approval and raised questions about its effectiveness, sending Bayer shares down more than 7 percent.
September 6th, 2011
Posted in
Drug